Heart Failure
121 - 135 of
205 Results
Sort Results:
Commentary:
FDA to Lift Some Avandia (Rosiglitazone) Prescribing/Dispensing Restrictions
January 2014
Article:
Experts will debate whether gliptins (Onglyza, etc) increase cardiovascular risk in patients with type 2 diabetes
November 2013